In these three short-term cases, the CardioWrap® Bioresorbable Protective Sheet has proven to be a cost effective and an inert product for pericardium replacement in procedures which may require reoperation within six months. However, these three cases are short-term observations and should be interpreted accordingly. Further investigation is absolutely required to determine the efficacy of the CardioWrap® sheet in other cardiac surgery procedures in which re-entry is likely (e.g. congenital cases, young adults).
Application of CardioWrap® Bioresorbable Protective Sheet in Cardiothoracic Procedures
r.sasany2020-08-22T12:40:12+04:3022nd August, 2020|Cardiowrap|0 Comments
Leave A Comment